BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15732187)

  • 1. Fitting a square peg into a round hole?: imposing informed consent and post-trial obligations on United States sponsored clinical trials in developing countries.
    Chang E
    South Calif Interdiscip Law J; 2002; 11(2):339-60. PubMed ID: 15732187
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials face heightened scrutiny as science and commerce appear to merge.
    Lorman AJ
    J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.
    Farrell K
    J Health Care Law Policy; 2006; 9(1):136-61. PubMed ID: 17165228
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA to weigh test of blood substitute out of public view.
    Burton T
    Wall St J (East Ed); 2006 Jul; ():D3. PubMed ID: 16906688
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations.
    Kelleher F
    Columbia J Law Soc Probl; 2004; 38(1):67-106. PubMed ID: 16755695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Light, fast, and flexible: a new approach to regulation of human gene therapy.
    Cregan JA
    McGeorge Law Rev; 2000; 32(1):261-87. PubMed ID: 15709266
    [No Abstract]   [Full Text] [Related]  

  • 7. Protecting human research subjects.
    Fiscus PW
    J Biolaw Bus; 2001; 4(4):18-22. PubMed ID: 12751493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In that case: your company has invested heavily in developing an AIDS vaccine and wishes to embark on clinical trials. Commentary.
    Evans D
    N Z Bioeth J; 2001 Oct; 2(3):37-8. PubMed ID: 15587008
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating clinical research: informed consent, privacy, and IRBs.
    Hoffman S
    Cap Univ Law Rev; 2003; 31(1):71-91. PubMed ID: 15295833
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA to weigh using fake blood in trauma trial.
    Burton TM
    Wall St J (East Ed); 2006 Jul; ():B1, B2. PubMed ID: 16909496
    [No Abstract]   [Full Text] [Related]  

  • 11. RNA interference: a critical analysis of the regulatory and ethical issues encountered in the development of a novel therapy.
    McKnight R
    Albany Law J Sci Technol; 2004; 15(1):73-108. PubMed ID: 17340758
    [No Abstract]   [Full Text] [Related]  

  • 12. Trials and errors: barriers to oversight of research conducted under the emergency research consent waiver.
    Kipnis K; King NM; Nelson RM
    IRB; 2006; 28(2):16-9. PubMed ID: 16770884
    [No Abstract]   [Full Text] [Related]  

  • 13. Informed consent for Alzheimer's disease clinical trials: a survey of clinical investigators.
    Karlawish JH; Knopman D; Clark CM; Morris JC; Marson D; Whitehouse PJ; Kawas CH
    IRB; 2002; 24(5):1-5. PubMed ID: 12737167
    [No Abstract]   [Full Text] [Related]  

  • 14. When informed consent is not required in studies.
    Maloney DM
    Hum Res Rep; 2006 Jun; 21(6):3. PubMed ID: 17111532
    [No Abstract]   [Full Text] [Related]  

  • 15. The basics of human subjects protection.
    Yoder LH
    Medsurg Nurs; 2006 Apr; 15(2):95-8; quiz 99. PubMed ID: 16700248
    [No Abstract]   [Full Text] [Related]  

  • 16. Research subject's complaint launches federal investigation.
    Maloney DM
    Hum Res Rep; 2003 Jan; 18(1):6-7. PubMed ID: 12755096
    [No Abstract]   [Full Text] [Related]  

  • 17. The use and disclosure of protected health information for research under the HIPAA privacy rule: unrealized patient autonomy and burdensome government regulation.
    Tovino SA
    S D Law Rev; 2004; 49(3):447-502. PubMed ID: 16493842
    [No Abstract]   [Full Text] [Related]  

  • 18. Continued concern: human subject protection, the institutional review board, and continuing review.
    Hoffman S
    Tenn Law Rev; 2001; 68(4):725-70. PubMed ID: 16189912
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of placebos in clinical trials: responsible research or unethical practice?
    Hoffman S
    Conn Law Rev; 2001; 33(2):449-501. PubMed ID: 15732201
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug companies cut costs with foreign clinical trials.
    Rai S
    N Y Times Web; 2005 Feb; ():C4. PubMed ID: 15742516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.